Updating the Chemistry and Biology of Cannabinoid CB2 Receptor – Specific Inverse Agonists

2010 ◽  
Vol 10 (8) ◽  
pp. 768-778 ◽  
Author(s):  
Charles A. Lunn
2011 ◽  
Vol 18 (8) ◽  
pp. 1053-1064 ◽  
Author(s):  
Wolfgang Schuehly ◽  
Juan Manuel Viveros Paredes ◽  
Jonas Kleyer ◽  
Antje Huefner ◽  
Sharon Anavi-Goffer ◽  
...  

2013 ◽  
Vol 4 (4) ◽  
pp. 387-392 ◽  
Author(s):  
Qin Ouyang ◽  
Qin Tong ◽  
Rentian Feng ◽  
Kyaw-Zeyar Myint ◽  
Peng Yang ◽  
...  

2006 ◽  
Vol 49 (6) ◽  
pp. 2022-2027 ◽  
Author(s):  
Katri H. Raitio ◽  
Juha R. Savinainen ◽  
Jouko Vepsäläinen ◽  
Jarmo T. Laitinen ◽  
Antti Poso ◽  
...  

2006 ◽  
Vol 68 (6) ◽  
pp. 334-340 ◽  
Author(s):  
Katri H. Raitio ◽  
Juha R. Savinainen ◽  
Tapio Nevalainen ◽  
Tomi Järvinen ◽  
Jouko Vepsäläinen

2010 ◽  
Vol 61 (4) ◽  
pp. 349-354 ◽  
Author(s):  
Maria Grazia Cascio ◽  
Daniele Bolognini ◽  
Roger G. Pertwee ◽  
Enza Palazzo ◽  
Federico Corelli ◽  
...  

2020 ◽  
Vol 44 (37) ◽  
pp. 16218-16226
Author(s):  
Claudia Mugnaini ◽  
Antonella Brizzi ◽  
Giorgia Vinciarelli ◽  
Marco Paolino ◽  
Federico Corelli

This synthesis of pyrazolo[4,3-b]pyridine-5-one derivatives, recently described as potent and selective agonists/inverse agonists of the cannabinoid type-2 receptor (CB2R), allows for a wider exploration of the structure-activity relationship.


Sign in / Sign up

Export Citation Format

Share Document